BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1404131)

  • 1. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage.
    Greenwald RA; Moak SA; Ramamurthy NS; Golub LM
    J Rheumatol; 1992 Jun; 19(6):927-38. PubMed ID: 1404131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
    Duivenvoorden WC; Hirte HW; Singh G
    Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis.
    Zernicke RF; Wohl GR; Greenwald RA; Moak SA; Leng W; Golub LM
    J Rheumatol; 1997 Jul; 24(7):1324-31. PubMed ID: 9228132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenidap and flurbiprofen enhance uptake of matrix metalloproteinase inhibitor 4-dedimethylaminotetracycline in inflamed joints of adjuvant arthritic rats.
    Leung MK; Greenwald RA; Ramamurthy NS; Moak SA; Koszulinski R; Dieudonne D; Golub LM
    J Rheumatol; 1995 Sep; 22(9):1726-31. PubMed ID: 8523353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetracyclines (TCs) inhibit matrix metalloproteinases (MMPs): in vivo effects in arthritic and diabetic rats and new in vitro studies.
    Golub L; Greenwald R; Ramamurthy N; Zucker S; Ramsammy L; McNamara T
    Matrix Suppl; 1992; 1():315-6. PubMed ID: 1480048
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of epiphyseal cartilage collagenase by tetracyclines in low phosphate rickets in rats.
    Greenwald RA; Simonson BG; Moak SA; Rush SW; Ramamurthy NS; Laskin RS; Golub LM
    J Orthop Res; 1988; 6(5):695-703. PubMed ID: 2841440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetracycline inhibition identifies the cellular sources of collagenase in gingival crevicular fluid in different forms of periodontal diseases.
    Suomalainen K; Halinen S; Ingman T; Lindy O; Saari H; Konttinen YT; Golub LM; Sorsa T
    Drugs Exp Clin Res; 1992; 18(3):99-104. PubMed ID: 1425210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats aged 0-21 days: II. Two proteinases, gelatinase B and collagenase-3, are implicated in the lysis of collagen fibrils.
    Davoli MA; Lamplugh L; Beauchemin A; Chan K; Mordier S; Mort JS; Murphy G; Docherty AJ; Leblond CP; Lee ER
    Dev Dyn; 2001 Sep; 222(1):71-88. PubMed ID: 11507770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host modulation with tetracyclines and their chemically modified analogues.
    Golub LM; Suomalainen K; Sorsa T
    Curr Opin Dent; 1992 Mar; 2():80-90. PubMed ID: 1325849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nonantimicrobial properties of tetracycline for the treatment of periodontal disease.
    Vernillo AT; Ramamurthy NS; Golub LM; Rifkin BR
    Curr Opin Periodontol; 1994; ():111-8. PubMed ID: 8032451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional sites of chemically modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases.
    Sorsa T; Ramamurthy NS; Vernillo AT; Zhang X; Konttinen YT; Rifkin BR; Golub LM
    J Rheumatol; 1998 May; 25(5):975-82. PubMed ID: 9598901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanadate, an inhibitor of stromelysin and collagenase expression, suppresses collagen induced arthritis.
    Oliver SJ; Firestein GS; Arsenault L; Cruz TF; Cheng TP; Banquerigo ML; Boyle DL; Brahn E
    J Rheumatol; 2007 Sep; 34(9):1802-9. PubMed ID: 17696279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
    Smith RJ; Sly LM
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH; Lottspeich F; Ries C; Petrides PE
    Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary collagen type II C-telopeptide fragments are sensitive markers of matrix metalloproteinase-dependent cartilage degradation in rat adjuvant-induced arthritis.
    De Ceuninck F; Sabatini M; Renoux V; de Nanteuil G; Pastoureau P
    J Rheumatol; 2003 Jul; 30(7):1561-4. PubMed ID: 12858459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage.
    Smith GN; Yu LP; Brandt KD; Capello WN
    J Rheumatol; 1998 Mar; 25(3):532-5. PubMed ID: 9517776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of naproxen on composition, proteoglycan metabolism, and matrix metalloproteinase activities in canine articular cartilage.
    Ratcliffe A; Azzo W; Saed-Nejad F; Lane N; Rosenwasser MP; Mow VC
    J Orthop Res; 1993 Mar; 11(2):163-71. PubMed ID: 8483029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
    Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
    J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and systemic factors in periodontal disease increase matrix-degrading enzyme activities in rat gingiva: effect of micocycline therapy.
    Chang KM; Ryan ME; Golub LM; Ramamurthy NS; McNamara TF
    Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):303-18. PubMed ID: 8829770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.
    Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B
    Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.